^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    AV-GBM-1

    i
    Company:
    AiVita Biomedical
    Drug class:
    Immunostimulant
    Related drugs:
    Apply
    AV-GBM-1 vs Control as Adjunctive Therapy Following Surgery and RT/TMZ in Newly Diagnosed GBM (NCT05100641)
    Phase 3
    Aivita Biomedical, Inc.
    Not yet recruiting
    Last update posted :
    04/10/2023
    Initiation :
    01/01/2024
    Primary completion :
    03/01/2028
    Completion :
    03/01/2029
    MGMT
    |
    temozolomide • AV-GBM-1